It also benefits the DoD by fostering the development of information on the determinants of disease and good health in service members and veterans.
The JPC’s mission and vision are focused on the DoD and the rest of the federal government but do not preclude working with other entities. The committee does not believe that there are any intrinsic advantages or disadvantages to any particular set of potential users of the repository’s resources. The committee recommends that there be no a priori restrictions on which applicants may apply for access to the repository’s specimens and data.
When data or specimens are disseminated to outside investigators, the JPC must be especially attentive to employing mechanisms to manage privacy and security issues properly. The committee recommends that the JPC condition its provision of repository materials to researchers outside of the federal government on
Asterand. 2008. Assessment of the Department of Defense’s tissue repository located at the Armed Forces of Pathology in Washington DC. Detroit, MI: Asterand, Inc.
Baker personal communication. 2011. Responses to questions posed by the Institute of Medicine Committee on the Review of the Appropriate Use of AFIP’s Tissue Repository Following Its Transfer to the Joint Pathology Center by COL Thomas P. Baker, MD, Interim Director, Joint Pathology Center. September 6, 2011. A copy of this document is available from The National Academies Public Access Records Office.
Baker TP. 2011. The Joint Pathology Center. April 21, 2011 presentation to the Committee on the Appropriate Use of the Armed Forces Institute of Pathology’s Tissue Repository Following Its Transfer to the Joint Pathology Center. Washington, DC: Institute of Medicine.